ASH 2013: Dr. Wiestner Discusses Why Therapy i... - CLL Support

CLL Support

22,370 members38,481 posts

ASH 2013: Dr. Wiestner Discusses Why Therapy in CLL Needs to be Individualized

bkoffman profile image
bkoffmanCLL CURE Hero
4 Replies

Friends,

I just posted my first interview from ASH 2013 where Dr. Wiestner discusses in some depth the heterogeneity of our disease and the treatment implications

Check out bkoffman.blogspot.com

On my way home form meeting some patient advocates and enjoying Greece.

Stay strong

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
4 Replies
Ernest2 profile image
Ernest2

Many thanks Brian, it's an education. That helped to put a lot of things together.

Been thinking of the word spectrum for a while, so good to hear it from an expert.

And great to see you looking well again, hope the problems a bit back have now subsided.

Best wishes for Christmas to everyone, and have a great new year.

Ernest.

bkoffman profile image
bkoffmanCLL CURE Hero in reply to Ernest2

Thanks. Happy holidays.

thewaitinggame profile image
thewaitinggame

You are a good man Brian and thanks.

All have a great festive season.

Alistair

jangreen profile image
jangreen

Hi Many thanks for all your videos it helps to explain this disease. Best wishes have a Merry Christmas and a Healthy New Year.

You may also like...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

Friends In another interview from ASH 2013 that I just posted on my blog...

iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.

getting and staying in deep and easy remissions, we have more work to do. Stay strong. Brian

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

Hi friends In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

blogspot.com Stay strong. We are all in this together. Brian http://cllsociety.org

ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"

of Patient Power, asks Dr Sharman to discuss whether emerging therapies will replace FCR....